drug eluting stents - Globe Thesis

Keyword [drug eluting stents] Result: 81 - 100 \| Page: 5 of 7
81.	Meta-analysis Of Short Versus Long Term Dual Antiplatelet Therapy After Second-generation Drug-eluting Stents Implantation
82.	Clinical Analysis Of Stent Thrombosis After Drug-eluting Implantation
83.	Clinical Study On Endovascular Angioplasty For The Treatment Of Vertebral Artery Origin Stenosis
84.	Evaluation Cardiac Coated Stents Security By The Effects Of Rapamycin On Human Umbilical Vein Endothelial Cells
85.	Clinical Efficacy Of Drug-coated Balloon With The Second Generation Of Drug Eluting Stents In The Treatment Of Coronaryartery In-stent Restenosis
86.	One Year Size Change Of Aneurysm After New-Generation Drug-Eluting Stents Implantation In Severe Stenosis Lesions With Focal Coronary Artery Aneurysm-A Retrospective Study
87.	Effects Of Different Interventional Strategies On The Prognosis Of Coronary Artery Ostium Lesions
88.	Risk Factors And Correlation For Coronary Stent Fracture
89.	Meta Analysis Of Second-generation Drug-Coated Balloon Versus Second-generation Drug-Eluting Stent In The Treatment Of Small Coronary Vessels
90.	The Effect Of Lp(a)on In-stent Restenosis And Development Of Non-Target Coronary Lesions In CAD Patients With Drug-Eluting Stents
91.	Factors Influencing In-Stent Restenosis After Percutaneous Coronary Intervention
92.	Safety And Efficacy Of Permanent Polymer,Biodegradable Polymer And Polymer-free Drug-eluting Stents During Unprotected Left Main Lesion PCI
93.	Analysis Of The Influencing Factors Of The Restenosis In Coronary Drug Eluting Stents
94.	Meta-analysis Of Efficacy And Safety Of The Absorb Bioresorbable Vascular Scaffolds Versus Second-generation Drug-eluting Stents With ST-segment Elevation Myocardial Infarction
95.	Application Of IVUS In Drug-eluting Stents Implanted In Coronary CTO Lesions
96.	Clinical Study On Endovascular Stenting For The Vertebral Artery Origin Stenosis
97.	Comparison Of Clinical Effects Of Drug-Coated Balloon And Drug-Eluting Stent On Marginal In-Stent Restenosis
98.	Correlation Between Lymphocyte/monocyte Ratio And Drugeluting Stents' In-stent Restenosis In Patients With Unstable Angina Pectoris
99.	Drug-Eluting Stents in New York State: Utilization, Disparities, Cost, Outcomes and Practice Variation
100.	Nanoparticles and drug eluting stents for disease detection and treatment
<<First <Prev Next> Last>> Jump to